FDA Import Refusal N90-0944251-4/166/1 — CP Pharmaceuticals Limited
The FDA refused shipment N90-0944251-4/166/1 from CP Pharmaceuticals Limited (United Kingdom) on Mar 23, 2017. The refused product falls under Drugs and Biologics — TAMOXIFEN CITRATE (ANTI-ESTROGEN). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 23, 2017
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61UCB05 TAMOXIFEN CITRATE (ANTI-ESTROGEN)
- Charges
- 75